Keyphrases
Lymphedema
100%
Sentinel Lymph Node Mapping
100%
Low-grade Endometrial Cancer
100%
Lower Limb Lymphedema
41%
After Surgery
23%
Lymph Node Metastasis
17%
Confidence Interval
11%
Body Mass Index
11%
Quality of Life
11%
Cancer Treatment
11%
Patient-Reported Outcomes Measurement Information System (PROMIS)
11%
Specific Quality of Life
11%
European Organizations
11%
Condition-dependent
11%
Myometrial Invasion
11%
Difference Scores
11%
Risk Factors
5%
Low Risk
5%
Clinical Significance
5%
Prospective Cohort Study
5%
Clinically Significant
5%
High-score
5%
Multiple Linear Regression Model
5%
Change from Baseline
5%
Large Group
5%
Before Surgery
5%
Metastasis
5%
Groin
5%
Disease-specific Quality of Life
5%
Domain Scores
5%
Genital
5%
Micrometastasis
5%
Baseline Predictors
5%
Negatively Associated
5%
Daily Activities
5%
Emotional Functioning
5%
Endometrial Cancer
5%
Staging Procedures
5%
Pelvic Lymphadenectomy
5%
Subjective Symptoms
5%
Symptom Burden
5%
EN24
5%
Surgical Staging
5%
Macrometastasis
5%
EORTC QLQ
5%
Global Quality of Life
5%
Minimally Invasive Surgical Procedures
5%
Quality of Life Tools
5%
Leg Swelling
5%
Persistent Lymphedema
5%
Lymphedema Measurement
5%
Exact Rate
5%
Medicine and Dentistry
Uterine Cancer
100%
Sentinel Lymph Node
100%
Lymphedema
100%
Leg
30%
Quality of Life
26%
Lymph Node Metastasis
11%
Body Mass Index
7%
Patient-Reported Outcome
7%
Cancer Treatment
7%
Multiple Linear Regression Analysis
3%
Disease
3%
Prospective Cohort Study
3%
Metastatic Carcinoma
3%
Micrometastasis
3%
Pelvis Lymphadenectomy
3%
Leg Swelling
3%